Understanding the mental health needs of Scotland's prison population: a health needs assessment

Autor: Gilling McIntosh, Lindsey, Rees, Cheryl, Kelly, Caroline, Howitt, Sheila, Thomson, Lindsay

Publikováno v: Gilling McIntosh, L, Rees, C, Kelly, C, Howitt, S & Thomson, L 2023, ' Understanding the mental health needs of Scotland’s prison population : A health needs assessment ', Frontiers in psychiatry, vol. 14, 1119228 . https://doi.org/10.3389/fpsyt.2023.1119228

IntroductionThis study reports on an assessment of mental health needs among Scotland's prison population which aimed to describe the scale and nature of need as well as identify opportunities to improve upon the services available. The project was c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8a35b18189b080c2189ee6834ea24b5
https://doi.org/10.3389/fpsyt.2023.1119228

Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder:CIAO-II study

Autor: Asherson, Philip, Johansson, Lena, Holland, Rachel, Bedding, Megan, Forrester, Andrew, Laura, Gianulli, Ginsberg, Ylva, Howitt, Sheila, Kretzschmar, Imogen, Lawrie, Stephen, Marsh, Craig, Kelly, Caroline, Mansfield, Megan, McCafferty, Clare, Khan, Khuram, Muller-Sedgwick, Ulrich, Strang, John, Williamson, Grace, Wilson, Lauren, Young, Susan, Landau, Sabine, Thomson, Lindsay

Publikováno v: Asherson, P, Johansson, L, Holland, R, Bedding, M, Forrester, A, Laura, G, Ginsberg, Y, Howitt, S, Kretzschmar, I, Lawrie, S, Marsh, C, Kelly, C, Mansfield, M, McCafferty, C, Khan, K, Muller-Sedgwick, U, Strang, J, Williamson, G, Wilson, L, Young, S, Landau, S & Thomson, L 2022, ' Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder : CIAO-II study ', British Journal of psychiatry, pp. 1 . https://doi.org/10.1192/bjp.2022.77

(237/300 words)Background: 20-30% of prisoners meet diagnostic criteria for attention-deficit/hyperactivity disorder (ADHD). Methylphenidate reduces ADHD symptoms but effects in prisoners are uncertain due to 16 comorbid mental health and substance u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2761::4fbb9a0506b96b2387c6d0aa3a67814e
https://kclpure.kcl.ac.uk/ws/files/174583518/Asherson_CIAO_BJPsych.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

OROS-methylphenidate to reduce ADHD symptoms in male prisoners aged 16–25 years: a RCT

Autor: Asherson P; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK; South London and Maudsley NHS Foundation Trust, London, UK; Oxleas NHS Foundation Trust, Dartford, UK, Johansson L; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK, Holland R; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK, Bedding M; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK, Forrester A; Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK; Offender Health Research Network, University of Manchester, Manchester, UK, Giannulli L; Division of Psychiatry, University of Edinburgh, Edinburgh, UK, Ginsberg Y; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institute, Stockholm, Sweden, Howitt S; Division of Psychiatry, University of Edinburgh, Edinburgh, UK; The Board, The State Hospital, Carstairs, UK, Kretzschmar I; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK, Lawrie S; Division of Psychiatry, University of Edinburgh, Edinburgh, UK, Marsh C; NHS Forth Valley, Stirling, UK, Kelly C; Division of Psychiatry, University of Edinburgh, Edinburgh, UK, Mansfield M; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK, McCafferty C; The Board, The State Hospital, Carstairs, UK, Khan K; The Board, The State Hospital, Carstairs, UK, Müller-Sedgwick U; Barnet, Enfield and Haringey Mental Health NHS Trust, London, UK, Strang J; Addiction Department, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK, Williamson G; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK, Wilson L; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK, Young S; Psychology Services Ltd, Croydon, UK, Landau S; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK, Thomson L; Division of Psychiatry, University of Edinburgh, Edinburgh, UK; The Board, The State Hospital, Carstairs, UK

Publikováno v: 2022 Jun.